BCEL — Atreca Share News
0.000.00%
Last trade - 00:00Immunotherapy biotech Atreca slides on $125 mln share offering
Brief: Atreca, Inc. Announces Pricing Of Underwritten Public Offering Of Common Stock
Brief: Atreca Inc Announces Proposed Underwritten Public Offering Of Class A Common Stock
Brief: Atreca And Xencor Enter Strategic Collaboration To Discover, Develop And Commercialize Novel T Cell Engaging Bispecific Antibodies
Brief: Xencor And Atreca Enter Strategic Collaboration To Discover, Develop And Commercialize Novel T Cell Engaging Bispecific Antibodies
Brief: Atreca Inc Files For Mixed Shelf Of Up To $300 Million
Brief: Atreca Files For Shelf Of Up To 9.5 Million Shares Of Class A Common Stock By Selling Stockholders
Brief: Atreca Q1 Loss Per Share $0.73
Brief: IGM Biosciences, Atreca, Beigene To Collaborate To Help Address Covid-19
U.S. RESEARCH ROUNDUP-Cambium Networks, Compass Diversified Holdings, Zendesk
U.S. RESEARCH ROUNDUP-Boston Properties, Five9, Twitter
Nasdaq Trade Halt Market Wide Circuit Breaker Halt: LEVEL 1 AT 08:41 AM
Brief: Atreca Announces First Patient Dosed In Phase 1B Clinical Trial Of ATRC-101
Brief: Atreca Announces Collaboration With Merck
NASDAQ RESUMED AT 03:19 PM
NASDAQ RESUMED AT 03:14 PM
NASDAQ RESUMED AT 02:10 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:05 PM
Brief: Atreca Inc and Serimmune Establish Research Collaboration Agreement In Oncology